Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie R Power Coombs

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2020
Assessing the Impact of Phytochemicals on Immune Checkpoints: Implications for Cancer ImmunotherapyMelanie R Power Coombs, David W Hoskin
Frontiers in Immunology|April 28, 2022
Editorial: Immune Modulation by FlavonoidsDavid W Hoskin, Melanie R Power Coombs
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Investigating Potential Applications of the Fish Anti-Microbial Peptide Pleurocidin: A Systematic ReviewKatelyn A M McMillan, Melanie R Power Coombs
Molecules (Basel, Switzerland)|November 25, 2020
Review: Examining the Natural Role of Amphibian Antimicrobial Peptide MagaininKatelyn A M McMillan, Melanie R Power Coombs
Clinical & Developmental Immunology|August 13, 2013
Neonatal host defense against Staphylococcal infectionsMelanie R Power Coombs, Kenny Kronforst, Ofer Levy
Molecular Medicine Reports|August 30, 2017
Thy-1 stimulation of mouse T cells induces a delayed T cell receptor-like signal that results in Ca2+‑independent cytotoxicitySuzanne Furlong, Melanie R Power Coombs, David W Hoskin
Cancer Letters|July 6, 2016
Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cellsMelanie R Power Coombs, Megan E Harrison, David W Hoskin
Plos One|July 16, 2015
4T1 Murine Mammary Carcinoma Cells Enhance Macrophage-Mediated Innate Inflammatory ResponsesLaurence Madera, Anna Greenshields, Melanie R Power Coombs, et al.
Frontiers in Oncology|February 7, 2022
The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential TargetingOlivia L Walker, Margaret L Dahn, Melanie R Power Coombs, et al.
Frontiers in Cell and Developmental Biology|December 12, 2018
Thy-1 (CD90) Signaling Preferentially Promotes RORγt Expression and a Th17 ResponseSuzanne Furlong, Melanie R Power Coombs, Javad Ghassemi-Rad, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2020
Assessing the Impact of Phytochemicals on Immune Checkpoints: Implications for Cancer ImmunotherapyMelanie R Power Coombs, David W Hoskin
Frontiers in Immunology|April 28, 2022
Editorial: Immune Modulation by FlavonoidsDavid W Hoskin, Melanie R Power Coombs
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Investigating Potential Applications of the Fish Anti-Microbial Peptide Pleurocidin: A Systematic ReviewKatelyn A M McMillan, Melanie R Power Coombs
Molecules (Basel, Switzerland)|November 25, 2020
Review: Examining the Natural Role of Amphibian Antimicrobial Peptide MagaininKatelyn A M McMillan, Melanie R Power Coombs
Clinical & Developmental Immunology|August 13, 2013
Neonatal host defense against Staphylococcal infectionsMelanie R Power Coombs, Kenny Kronforst, Ofer Levy
Molecular Medicine Reports|August 30, 2017
Thy-1 stimulation of mouse T cells induces a delayed T cell receptor-like signal that results in Ca2+‑independent cytotoxicitySuzanne Furlong, Melanie R Power Coombs, David W Hoskin
Cancer Letters|July 6, 2016
Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cellsMelanie R Power Coombs, Megan E Harrison, David W Hoskin
Plos One|July 16, 2015
4T1 Murine Mammary Carcinoma Cells Enhance Macrophage-Mediated Innate Inflammatory ResponsesLaurence Madera, Anna Greenshields, Melanie R Power Coombs, et al.
Frontiers in Oncology|February 7, 2022
The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential TargetingOlivia L Walker, Margaret L Dahn, Melanie R Power Coombs, et al.
Frontiers in Cell and Developmental Biology|December 12, 2018
Thy-1 (CD90) Signaling Preferentially Promotes RORγt Expression and a Th17 ResponseSuzanne Furlong, Melanie R Power Coombs, Javad Ghassemi-Rad, et al.
Pageof 3